PS
BIO icon

Principal Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Principal Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
4,352
-33
-0.8% -$9.36K 0.02% 700
2026
Q1 		$1.22M Buy
4,385
+113
+3% +$32.5K 0.02% 656
2025
Q4 		$1.29M Buy
4,272
+1,273
+42% +$397K 0.02% 625
2025
Q3 		$841K Buy
2,999
+69
+2% +$18.8K 0.01% 723
2025
Q2 		$707K Sell
2,930
-64
-2% -$15.1K 0.01% 719
2025
Q1 		$984K Hold
2,994
– – 0.02% 560
2024
Q4 		$984K Buy
2,994
+2,807
+1,501% +$953K 0.02% 556
2024
Q3 		$62.6K Buy
187
+1
+0.5% +$318 ﹤0.01% 1594
2024
Q2 		$50.8K Buy
186
+17
+10% +$4.94K ﹤0.01% 1617
2024
Q1 		$58.5K Buy
169
+41
+32% +$13.5K ﹤0.01% 1500
2023
Q4 		$41.3K Buy
+128
New +$40.1K ﹤0.01% 1571

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Principal Securities's BIO Position: Q2 2026 in Review

Principal Securities reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.75% in Q2 2026, selling an estimated $9.36K and leaving 4,352 shares worth $1.28M. The position accounts for 0.02% of the portfolio, ranked #700.

Principal Securities first reported a position in BIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.29M in Q4 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Principal Securities held 4,352 shares of Bio-Rad Laboratories Class A worth $1.28M as of Q2 2026.
  • Principal Securities sold 33 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $9.36K.
  • Bio-Rad Laboratories Class A made up 0.02% of Principal Securities's portfolio in Q2 2026, its #700 holding.
  • Principal Securities first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's Bio-Rad Laboratories Class A position peaked at $1.29M in Q4 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.